Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.950
+0.020 (0.68%)
At close: Nov 9, 2026, 4:00 PM EST
2.890
-0.060 (-2.03%)
After-hours: Nov 9, 2026, 4:17 PM EST
Apyx Medical Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Apyx Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 120.34% higher than the current stock price, while the lowest is $6.00 (+103.39%) and the highest is $8.00 (+171.19%).
Price Target: $6.50 (+120.34%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $6 | Buy | Reiterates | $6 | +103.39% | Nov 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +137.29% | Nov 6, 2026 |
| BTIG | BTIG | Buy Reiterates $6 | Buy | Reiterates | $6 | +103.39% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
59.41M
from 52.84M
Increased by 12.42%
Revenue Next Year
65.97M
from 59.41M
Increased by 11.05%
EPS This Year
-0.27
from -0.27
EPS Next Year
-0.25
from -0.27
EPS and Forward PE are based on non-GAAP adjusted numbers.